Search results
“We have a superb portfolio of brands, which have momentum” – Pernod Ricard on prospects in gin
Just Drinks· 2 hours agoPernod Ricard is spending €25m ($27.1m) on a new distillery for its Ki No Bi gin brand in Japan. The...
Kwon Eun Bi's agency issues warning about legal action will be taken against sexual harassment,...
Pinkvilla· 3 days agoWoollim Entertainment, Kwon Eun Bi's agency, has issued a statement regarding legal actions against...
New bi-weekly train to be run soon between Secunderabad and Goa
The Hindu· 2 days agoA new bi-weekly express train will be operated soon between Secunderabad and Goa benefiting the people of two Telugu States who wish to visit Goa. The Secunderabad-Vasco da ...
Kwon Eun Bi's agency issues strong warning on sexual harassment and fake content | K-pop Movie News...
The Times of India· 3 days agoWoollim Entertainment has issued a strong statement regarding their ongoing efforts to safeguard the...
Andrew Tate launches bizarre misogynistic rant after Romania court verdict: ‘I am free…’
Hindustan Times· 3 days agoThis comes after Bucharest court announced that Tate and his brother Tristan are allowed to leave...
Godox ML60II Bi review: powerful LED light for video creators in a studio or on location
Digital Camera World· 5 days agoHowever, it also ships with an NP-F battery kit that lets me operate the LED handheld to illuminate...
TCS, HCL earnings recovery may get further push from growth in AI demand
Business Standard India· 9 hours agoTCS results this week should show revenue growth picked up sequentially in the April-June quarter,...
7 Kim Go Eun movies and TV shows that are must-watch for every K-drama fan; Goblin, Exhuma and more
Pinkvilla· 3 days agoIf you are new to the world of everything Korean, these 7 Kim Go Eun movies and TV shows are an...
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena· 6 days agoBoehringer Ingelheim and Gubra have initiated a Phase I clinical trial of BI 3034701, a long-acting...
Boehringer and OSE to advance cancer immunotherapy to clinics
Pharmaceutical Technology· 4 days agoBoehringer Ingelheim and OSE Immunotherapeutics have announced the progression of a SIRPα inhibitor...